While vaccine debates make for great political fodder, the bottom line is that most of us are alive today because of vaccines. And in the case of messenger RNA vaccines, this is just the next evolution of vaccine science — and an amazing opportunity for investors to make a lot of money.

While market analyst Jeff Siegel has certainly taken advice from the Oracle of Omaha over the years, he’s also been very conscious of the fact that there’s more than one way to make a buck. And it doesn’t always have to be “Warren’s way.”

It all went down on April 6… Wyoming Gov. Mark Gordon created a $1.2 million fund that would be used to help the state’s coal industry sue any state that blocks its coal exports.

While investors in both Bionomics and IntelGenx have seen double-digit gains in just the past week, there are three more psychedelics stocks that are poised to get a big pop within the next three weeks...

Although the psychedelics market is still very young, it is absolutely going to usher in one of the most disruptive waves of innovation the mental health industry has seen in decades. And right now, atai is the 800-pound gorilla in the psychedelics space.

The full-scale legalization of cannabis across the U.S. is coming, and you better believe a lot of money is going to be made. So you might as well get some of that action for yourself.